Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,796 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs.
Ishii K, Hasegawa H, Nagata N, Mizutani T, Morikawa S, Suzuki T, Taguchi F, Tashiro M, Takemori T, Miyamura T, Tsunetsugu-Yokota Y. Ishii K, et al. Among authors: hasegawa h. Virology. 2006 Aug 1;351(2):368-80. doi: 10.1016/j.virol.2006.03.020. Epub 2006 May 6. Virology. 2006. PMID: 16678878 Free PMC article.
Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection.
Asahi-Ozaki Y, Itamura S, Ichinohe T, Strong P, Tamura S, Takahashi H, Sawa H, Moriyama M, Tashiro M, Sata T, Kurata T, Hasegawa H. Asahi-Ozaki Y, et al. Among authors: hasegawa h. Microbes Infect. 2006 Oct;8(12-13):2706-14. doi: 10.1016/j.micinf.2006.07.018. Epub 2006 Aug 28. Microbes Infect. 2006. PMID: 16968669 Free article.
Pathological and virological analyses of severe acute respiratory syndrome-associated coronavirus infections in experimental animals.
Nagata N, Iwata N, Hasegawa H, Asahi-Ozaki Y, Sato Y, Harashima A, Morikawa S, Saijo M, Itamura S, Saito T, Odagiri T, Tashiro M, Ami Y, Sata T. Nagata N, et al. Among authors: hasegawa h. Adv Exp Med Biol. 2006;581:515-8. doi: 10.1007/978-0-387-33012-9_92. Adv Exp Med Biol. 2006. PMID: 17037588 Free PMC article. No abstract available.
Highly attenuated vaccinia virus DIs as a potential SARS vaccine.
Ishii K, Hasegawa H, Nagata N, Mizutani T, Morikawa S, Tashiro M, Suzuki T, Taguchi F, Takemori T, Miyamura T, Tsunetsugu-Yokota Y. Ishii K, et al. Among authors: hasegawa h. Adv Exp Med Biol. 2006;581:593-6. doi: 10.1007/978-0-387-33012-9_107. Adv Exp Med Biol. 2006. PMID: 17037603 Free PMC article. No abstract available.
Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge.
Ichinohe T, Kawaguchi A, Tamura S, Takahashi H, Sawa H, Ninomiya A, Imai M, Itamura S, Odagiri T, Tashiro M, Chiba J, Sata T, Kurata T, Hasegawa H. Ichinohe T, et al. Among authors: hasegawa h. Microbes Infect. 2007 Sep;9(11):1333-40. doi: 10.1016/j.micinf.2007.06.007. Epub 2007 Jul 1. Microbes Infect. 2007. PMID: 17890128 Free article.
Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine.
Ichinohe T, Tamura S, Kawaguchi A, Ninomiya A, Imai M, Itamura S, Odagiri T, Tashiro M, Takahashi H, Sawa H, Mitchell WM, Strayer DR, Carter WA, Chiba J, Kurata T, Sata T, Hasegawa H. Ichinohe T, et al. Among authors: hasegawa h. J Infect Dis. 2007 Nov 1;196(9):1313-20. doi: 10.1086/521304. Epub 2007 Oct 5. J Infect Dis. 2007. PMID: 17922395 Free PMC article.
Pathology and virus dispersion in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus via different inoculation routes.
Nagata N, Iwata N, Hasegawa H, Sato Y, Morikawa S, Saijo M, Itamura S, Saito T, Ami Y, Odagiri T, Tashiro M, Sata T. Nagata N, et al. Among authors: hasegawa h. Int J Exp Pathol. 2007 Dec;88(6):403-14. doi: 10.1111/j.1365-2613.2007.00567.x. Int J Exp Pathol. 2007. PMID: 18039277 Free PMC article.
Mechanism of NKT cell activation by intranasal coadministration of alpha-galactosylceramide, which can induce cross-protection against influenza viruses.
Kamijuku H, Nagata Y, Jiang X, Ichinohe T, Tashiro T, Mori K, Taniguchi M, Hase K, Ohno H, Shimaoka T, Yonehara S, Odagiri T, Tashiro M, Sata T, Hasegawa H, Seino KI. Kamijuku H, et al. Among authors: hasegawa h. Mucosal Immunol. 2008 May;1(3):208-18. doi: 10.1038/mi.2008.2. Epub 2008 Mar 5. Mucosal Immunol. 2008. PMID: 19079180 Free article.
3,796 results